We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

68 hedge funds and large institutions have $77.4M invested in Filana Therapeutics in 2020 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

340% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 5

326% more capital invested

Capital invested by funds: $18.2M → $77.4M (+$59.3M)

83% more call options, than puts

Call options by funds: $7.35M | Put options by funds: $4.01M

33% more funds holding

Funds holding: 51 → 68 (+17)

27% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 15

3.16% more ownership

Funds ownership: 24.19% → 27.35% (+3.2%)

Holders
68
Holders Change
+17
Holders Change %
+33.33%
% of All Funds
1.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
19
Reduced
15
Closed
5
Calls
$7.35M
Puts
$4.01M
Net Calls
+$3.34M
Net Calls Change
+$2.43M

Top Buyers

Rank Fund Capital Flow
1
ECM
ExodusPoint Capital Management
New York
+$1.3M
2
FMBTD
First Midwest Bank Trust Division
Illinois
+$705K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$686K
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$564K
5
State Street
State Street
Massachusetts
+$531K

Top Sellers

Rank Fund Capital Flow
1
BL
Bleichroeder LP
New York
-$1.65M
2
Group One Trading
Group One Trading
Illinois
-$444K
3
Citadel Advisors
Citadel Advisors
Florida
-$427K
4
Jane Street
Jane Street
New York
-$366K
5
N
Nuveen
North Carolina
-$146K
Name Holding Trade Value Shares
Change 		Change in
Stake
BNP Paribas Financial Markets
51
BNP Paribas Financial Markets
France
$72.5K +$24.5K +5,432 +626%
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
$70K +$194 +43 +0.7%
SQA
53
Simon Quick Advisors
New Jersey
$58K +$22.5K +5,000 New
JC
54
JBF Capital
Colorado
$46K +$18K +4,000 New
CG
55
Cutler Group
California
$39K -$5.3K -1,175 -26%
Legal & General Group
56
Legal & General Group
United Kingdom
$27K -$4.07K -902 -28%
AIP
57
Ameritas Investment Partners
Nebraska
$24K – – –
PAM
58
Panagora Asset Management
Massachusetts
$20K +$7.92K +1,757 New
Carson Wealth (CWM LLC)
59
Carson Wealth (CWM LLC)
Nebraska
$17K – – –
Citigroup
60
Citigroup
New York
$13K -$9.45K -2,096 -65%
Bank of Montreal
61
Bank of Montreal
Ontario, Canada
$12K -$139K -30,760 -97%
BCA
62
Berman Capital Advisors
Georgia
$11K +$4.48K +994 New
ASN
63
Advisory Services Network
Georgia
$8K +$2.98K +660 New
UBS Group
64
UBS Group
Switzerland
$5K -$41.9K -9,304 -95%
AWM
65
AllSquare Wealth Management
New York
$3K – – –
GWM
66
Geneos Wealth Management
Colorado
$1K +$649 +144 New
CM
67
Caption Management
Oklahoma
– -$103K -33,202 Closed
Squarepoint
68
Squarepoint
New York
– -$57K -18,554 Closed
VOYA Investment Management
69
VOYA Investment Management
Georgia
– -$40K -13,065 Closed
SG Americas Securities
70
SG Americas Securities
New York
– -$39K -12,576 Closed
RWB
71
RMR Wealth Builders
New Jersey
– -$3K -1,000 Closed
Simplex Trading
72
Simplex Trading
Illinois
– +$104K +23,140 +11,019%
1 2
3

FLNA Hedge Fund Activity: Q3 2020 in Review

68 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2020, worth a combined $77.4M — up 326% from $18.2M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new FLNA positions and 5 closed out — a net gain of 17 holders — while 19 added to existing stakes and 15 trimmed.

The largest buyer was ExodusPoint Capital Management, opening a new position worth an estimated $1.3M. The largest seller was Bleichroeder LP, cutting an estimated $1.65M.

  • 68 institutional investors held Filana Therapeutics (FLNA) as of Q3 2020, up from 51 in Q2 2020.
  • Funds reported $77.4M of Filana Therapeutics stock for Q3 2020, up 326% quarter-over-quarter.
  • 22 funds opened new Filana Therapeutics positions in Q3 2020 and 5 closed out, a net change of +17 holders.
  • The largest Filana Therapeutics buyer in Q3 2020 was ExodusPoint Capital Management, an estimated $1.3M added.
  • The largest Filana Therapeutics seller in Q3 2020 was Bleichroeder LP, an estimated $1.65M sold.

Based on aggregated 13F filings for Q3 2020.